Article
A Computational Workflow to Predict Biological Target Mutations: The Spike Glycoprotein Case Study.
Molecules (Basel, Switzerland) - 14 Oct 2023
Cozzini Pietro, Agosta Federica, Dolcetti Greta, Dal Palù Alessandro
Abstract excerpt
The biological target identification process, a pivotal phase in the drug discovery workflow, becomes particularly challenging when mutations affect proteins' mechanisms of action. COVID-19 Spike glycoprotein mutations are known to modify the affinity toward the human angiotensin-converting enzyme ACE2 and several antibodies, compromising their neutralizing effect. Predicting new possible mutations would be an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
